Grifols Announces FDA Approval of Xembify®, 20% Subcutaneous Immunoglobulin for Primary Immunodeficiencies

Life Science

Evotec completes acquisition of Just Biotherapeutics

Life Science

Citryll Completes First Closing of a € 15M Series A to Develop its NETosis Inhibiting Antibody

Life Science

Ocumension Signs $13.5 Million Deal for China Rights to Nicox Anti-Inflammatory Eye Drug

Life Science

Jibeier Pharm Files for IPO on Shanghai’s New Tech Innovation Board

Life Science

Asieris Enters $73 Million Agreement for Global Rights to Cervical Lesion Treatment

Life Science

Yuhan Out-Licenses NASH Treatment to Boehringer in $870 Million Deal

Life Science

China CAMC to Build USD62.4 Million Transport Hub in Cote d’Ivoire

Technology

CMS In-Licenses Dry Eye, Psoriasis Treatments from India’s Sun Pharma

Life Science

PeptiDream Announces New Peptide Drug Conjugate (“PDC”) Collaboration Agreement with Novartis

Life Science

Yisheng Cleared to Start China Trials of PIKA-based Cancer Immunotherapy

Life Science

Weibo Sees USD800 Million Singapore Bond Offering Oversubscribed Over Four Times

Technology

China’s Bossco to Sell USD22.8 Million Equipment to Indonesia’s Asia Pulp & Paper

Technology

Tasly Biopharma Files for Hong Kong IPO That Could Raise $1 Billion

Life Science

MicroPort Orthopedics Launches Improved Knee Replacement Product

Life Science